Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
- Written by PR Newswire
![]() |
At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment analysis.
SEOUL, South Korea, May 22, 2026 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today...
Read more: Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026















